218 related articles for article (PubMed ID: 23875777)
21. Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury.
Guha D; Wagner MCE; Ayyavoo V
J Neuroinflammation; 2018 Apr; 15(1):126. PubMed ID: 29703241
[TBL] [Abstract][Full Text] [Related]
22. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice.
McLane VD; Lark ARS; Nass SR; Knapp PE; Hauser KF
Neurosci Lett; 2022 Jun; 782():136688. PubMed ID: 35595189
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells.
Lu SM; Tremblay MÈ; King IL; Qi J; Reynolds HM; Marker DF; Varrone JJ; Majewska AK; Dewhurst S; Gelbard HA
PLoS One; 2011; 6(9):e23915. PubMed ID: 21912650
[TBL] [Abstract][Full Text] [Related]
25. Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.
Nash B; Festa L; Lin C; Meucci O
Brain Res; 2019 Nov; 1723():146409. PubMed ID: 31465771
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Neurobiol Dis; 2012 Feb; 45(2):657-70. PubMed ID: 22036626
[TBL] [Abstract][Full Text] [Related]
27. Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicity.
Eugenin EA; King JE; Hazleton JE; Major EO; Bennett MV; Zukin RS; Berman JW
Neurotox Res; 2011 Jan; 19(1):138-48. PubMed ID: 20094923
[TBL] [Abstract][Full Text] [Related]
28. D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.
Aksenov MY; Aksenova MV; Mactutus CF; Booze RM
J Neuroimmune Pharmacol; 2012 Sep; 7(3):599-608. PubMed ID: 22552781
[TBL] [Abstract][Full Text] [Related]
29. A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases.
Malik S; Khalique H; Buch S; Seth P
PLoS One; 2011 Mar; 6(3):e18116. PubMed ID: 21483469
[TBL] [Abstract][Full Text] [Related]
30. Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats.
Li J; Zeng B; Hu X; Li Z; Zhang D; Yang G; Dai J; Zeng X
Am J Chin Med; 2018; 46(3):551-566. PubMed ID: 29690789
[TBL] [Abstract][Full Text] [Related]
31. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons.
Aksenova MV; Aksenov MY; Adams SM; Mactutus CF; Booze RM
Exp Neurol; 2009 Feb; 215(2):253-63. PubMed ID: 19013459
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment.
Self RL; Mulholland PJ; Harris BR; Nath A; Prendergast MA
Alcohol Clin Exp Res; 2004 Dec; 28(12):1916-24. PubMed ID: 15608609
[TBL] [Abstract][Full Text] [Related]
33. Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.
Bruce-Keller AJ; Chauhan A; Dimayuga FO; Gee J; Keller JN; Nath A
J Neurosci; 2003 Sep; 23(23):8417-22. PubMed ID: 12968004
[TBL] [Abstract][Full Text] [Related]
34. Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders.
Chemparathy DT; Ray S; Ochs C; Ferguson N; Gawande DY; Dravid SM; Callen S; Sil S; Buch S
J Extracell Vesicles; 2024 Apr; 13(4):e12439. PubMed ID: 38647111
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation.
Aksenova M; Sybrandt J; Cui B; Sikirzhytski V; Ji H; Odhiambo D; Lucius MD; Turner JR; Broude E; Peña E; Lizarraga S; Zhu J; Safro I; Wyatt MD; Shtutman M
J Neuroimmune Pharmacol; 2020 Jun; 15(2):209-223. PubMed ID: 31802418
[TBL] [Abstract][Full Text] [Related]
36. Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage.
Denton AR; Mactutus CF; Lateef AU; Harrod SB; Booze RM
J Neurovirol; 2021 Jun; 27(3):403-421. PubMed ID: 34003469
[TBL] [Abstract][Full Text] [Related]
37. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.
Fitting S; Ignatowska-Jankowska BM; Bull C; Skoff RP; Lichtman AH; Wise LE; Fox MA; Su J; Medina AE; Krahe TE; Knapp PE; Guido W; Hauser KF
Biol Psychiatry; 2013 Mar; 73(5):443-53. PubMed ID: 23218253
[TBL] [Abstract][Full Text] [Related]
38. Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?
Nath A; Steiner J
Exp Neurol; 2014 Jan; 251():112-4. PubMed ID: 24246278
[No Abstract] [Full Text] [Related]
39. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders.
Fields J; Dumaop W; Eleuteri S; Campos S; Serger E; Trejo M; Kosberg K; Adame A; Spencer B; Rockenstein E; He JJ; Masliah E
J Neurosci; 2015 Feb; 35(5):1921-38. PubMed ID: 25653352
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of Neuronal Cholesterol Homeostasis upon Exposure to HIV-1 Tat and Cocaine Revealed by RNA-Sequencing.
Mohseni Ahooyi T; Shekarabi M; Torkzaban B; Langford TD; Burdo TH; Gordon J; Datta PK; Amini S; Khalili K
Sci Rep; 2018 Nov; 8(1):16300. PubMed ID: 30390000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
